FDA's New Guidance on Compounding Bulk Drug Substances

Audience: The program is tailored to IACUC staff, IACUC members, IOs, veterinarians, investigators, compliance personnel, animal care staff, and others involved in animal programs.

Speakers: Amber McCoig, DVM, MPH, Senior Veterinary Medical Officer, Science Policy, Office of the Director at the US Food and Drug Administration (FDA) Center for Veterinary Medicine

Dorothy Bailey, DVM, Veterinary Medical Officer in the Office of Minor Use and Minor Species Animal Drug Development at US FDA Center for Veterinary Medicine. 

Topic: In this webinar, Dr. Amber McCoig presents information on FDA’s new guidance for compounding from bulk substances, how FDA guidance applies to laboratory animal care and use, and answers questions from the laboratory animal community.

Dr. Bailey presents information on the Indexing program and explains the difference between FDA indexed, approved, and conditionally-approved drugs. 

The recording, slides, and transcript will be posted after 508 compliance processing for accessibility. 

Questions

Submit comments or questions here or send email OLAW at olawdpe@mail.nih.gov.

This page last updated on: Sep 30, 2022
Content Questions: E-mail OLAW
Technical Issues: E-mail Webmaster